RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$955M
AUM Growth
+$74.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
94
New
Increased
Reduced
Closed

Top Buys

1
+$13.5M
2
+$9.44M
3
+$9.29M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$8.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$7.92M

Top Sells

1
+$14.9M
2
+$12.2M
3
+$11.6M
4
ELV icon
Elevance Health
ELV
+$9.3M
5
PFE icon
Pfizer
PFE
+$8.84M

Sector Composition

1 Healthcare 98.85%
2 Industrials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$35.1M 3.68%
97,000
+7,000
2
$30.4M 3.19%
54,800
-1,200
3
$30M 3.14%
695,000
-30,000
4
$30M 3.14%
96,000
+1,000
5
$27M 2.83%
52,500
+15,400
6
$24.6M 2.57%
44,000
+1,000
7
$24.2M 2.54%
75,000
-36,000
8
$24M 2.51%
32,000
+18,000
9
$21.9M 2.29%
149,626
-40,374
10
$21.9M 2.29%
40,000
-17,000
11
$21.8M 2.28%
215,000
-50,000
12
$21.7M 2.27%
85,900
+12,900
13
$21.4M 2.24%
136,000
+11,000
14
$21.3M 2.23%
225,000
-65,000
15
$21.2M 2.22%
270,000
+70,000
16
$21M 2.2%
240,000
+90,000
17
$20.5M 2.15%
237,000
+97,000
18
$20.1M 2.1%
85,000
+40,000
19
$19.5M 2.04%
50,000
-13,000
20
$18.9M 1.98%
131,500
-28,500
21
$17.4M 1.82%
100,000
22
$16.3M 1.71%
350,000
-190,000
23
$15.6M 1.63%
69,936
+9,024
24
$15.5M 1.63%
75,000
25
$15.4M 1.61%
210,000
-30,000
1
2 3 4